|Year : 2017 | Volume
| Issue : 1 | Page : 16-23
Clinical evaluation of acute kidney injury in Al-Zahraa University Hospital, Cairo, Egypt
Lamyaa I Ahmed MD 1, Hayam H Mansour1, Amal Hussen1, Mohammed S Zaki2, Ragaa R Mohammed1, Aalaa T Goda1
1 Department of Internal Medicine, Faculty of Medicine for Girls, Al Azhar University, Cairo, Egypt
2 National Institute of Urology and Nephrology (NIUN), Cairo, Egypt
|Date of Submission||01-Jan-2017|
|Date of Acceptance||12-Mar-2017|
|Date of Web Publication||12-Jun-2017|
Lamyaa I Ahmed
Assistant Professor of Internal Medicine Al-Azhar, 145c shoubra st., Cairo
Source of Support: None, Conflict of Interest: None
Acute kidney injury (AKI) is a very common problem. Early detection of injury with initiation of appropriate supportive care remains the mainstay of therapy.
The aim of the present study was to evaluate the incidence, etiology, prognosis, treatment, and outcome of AKI.
Patients and methods
This was a prospective, observational study of 212 patients (137 men and 75 women) who were admitted in all departments of Al-Zahraa University Hospital with AKI during the period from October 2014 to October 2015. Their ages ranged from 22 to 85 years. We included adults aged more than 18 years who presented with AKI, and we excluded patients on regular dialysis. Serum creatinine, sodium, potassium, urea, calcium, phosphorus and uric acid, complete blood count, pelviabdominal ultrasound, and daily measurement of urine output (UOP) were done. AKI patients were classified according to the RIFLE and Acute Kidney Injury Network staging.
According to the RIFLE criteria, the number of risk, injury, failure, loss, and end-stage renal disease patients were 55 (25.9%), 62 (29.24%), 33 (15.56%), 38 (17.92%), and 24 (11.32%), respectively. According to the Acute Kidney Injury Network staging system, the number of stages I, II, and III patients were 61 (28.7%), 50 (23.5%), and 101 (47.6%), respectively. The length of hospital stay was significantly associated with severity of AKI. The main cause of AKI was dehydration in 82 (38.7%) patients and sepsis in 71 (33.5%). Oliguric patients were 147 (69.34%) and nonoliguric were 65 (30.66%). Moreover, prognosis of patients was complete recovery in 95 (44.81%), partial recovery in 81 (38.21%), and no recovery in 36 (16.98%).
AKI was more common among patients in ICU than those in any other department. Dehydration and sepsis were its leading causes.
Keywords: acute kidney injury, dehydration, sepsis
|How to cite this article:|
Ahmed LI, Mansour HH, Hussen A, Zaki MS, Mohammed RR, Goda AT. Clinical evaluation of acute kidney injury in Al-Zahraa University Hospital, Cairo, Egypt. Egypt J Intern Med 2017;29:16-23
|How to cite this URL:|
Ahmed LI, Mansour HH, Hussen A, Zaki MS, Mohammed RR, Goda AT. Clinical evaluation of acute kidney injury in Al-Zahraa University Hospital, Cairo, Egypt. Egypt J Intern Med [serial online] 2017 [cited 2021 Jan 28];29:16-23. Available from: http://www.esim.eg.net/text.asp?2017/29/1/16/207780
| Introduction|| |
Acute kidney injury (AKI) is recognized as a very common problem in critically ill patients, and is strongly associated with increased resource utilization, and higher short-term and long-term mortality ,.
The classic definition of AKI included rapid rise of serum creatinine accompanied by a dramatic decrease in urine output (UOP). Due to lagging in the rise of serum creatinine in parallel with the rapid decline in the glomerular filtration rate, other criteria had been included ,.
The RIFLE (Risk, Injury, Failure, Loss, and End-stage renal disease) criteria were the first widely accepted definition , and later, the Acute Kidney Injury Network (AKIN) criteria was modified RIFLE .
| Aim|| |
The presented study aimed to evaluate the incidence, etiology, prognosis, treatment, and outcome of AKI at AL-Zahraa University Hospital, Cairo, Egypt, over a period of 12 months.
| Patients and methods|| |
This prospective, observational study was conducted on 212 patients who were admitted in all departments of Al-Zahraa University Hospital with AKI during the period from October 2014 to October 2015. There were 137 (64.62%) male patients and 75 (35.38%) female patients, their ages ranging from 22 to 85 years. An informed consent was signed by the patients or their relatives before participation in the study. Approval for this study was obtained from the hospital’s Ethical Committee.
Adult patients over 18 years of age who were admitted to the hospital during the study period with AKI were enrolled to the study. Patients with end-stage renal disease (ESRD) and on regular dialysis were excluded from the study.
All patients of this study were submitted to the following:
- Full medical history, including drug history and surgical operations, full medical examination, and diagnosis at admission.
- Laboratory investigations, including serum creatinine (on admission, peak, and on discharge), urea, serum sodium, potassium, calcium, phosphorus, and uric acid. Daily measurement of UOP during admission period. Complete blood count, prothrombin time, prothrombin concentration, and international normalized ratio and pelviabdominal ultrasound were done for each patient.
Patients with AKI were classified according to the RIFLE classification and AKIN staging system ([Table 1] and [Table 2]).
Statistical analysis: Data were analyzed using Statistical Program for Social Science (SPSS) (SPSS, version 20.0). Quantitative data were expressed as mean±SD. Qualitative data were expressed as frequency and percentage. A one-way analysis of variance was carried out to compare between more than two means. The χ2 test of significance was used to compare proportions between two qualitative parameters.
| Results|| |
A total of 212 patients with AKI were studied (AKI was defined according to the RIFLE and AKIN staging of AKI and the patients were followed up for 6 months) − there were 137 (64.62%) male patients, of whom 74 (54.01%) were in stage III AKI according to the AKIN staging, and there were 75 (35.38%) female patients, on whom 27 (36%) were in stage III AKI according to the AKIN staging.
The ages of patients ranged from 22 to 85 years, with a mean±SD of 57.72±13.62 years ([Table 3]).
|Table 3 Demographic data of the studied patients and their relation to different acute kidney injury stages according to the Acute Kidney Injury Network staging|
Click here to view
According to the RIFLE criteria, the number of risk, injury, failure, loss, and ESRD in the studied patients were 55 (25.9%), 62 (29.24%), 33 (15.56%), 38 (17.92%), and 24 (11.32%), respectively ([Table 4]). According to the AKIN staging system, the number of stages I, II, and III in the studied patients were 61 (28.7%), 50 (23.5%), and 101 (47.6%), respectively ([Table 5]).
|Table 4 Acute kidney injury staging of 212 studied patients according to the RIFLE classification|
Click here to view
|Table 5 Acute kidney injury staging of 212 studied patients according to the Acute Kidney Injury Network classification|
Click here to view
Oliguria was noted in 147 (69.34%) patients and 65 (30.66%) patients were nonoliguric ([Figure 1]).
Patients allocated from different hospital departments including surgical ICU, medical ICU, internal medicine department, surgery department, urology department, chest department, ophthalmology department, orthopedics department, tropical department, and vascular department were 73 (34.43%), 58 (27.36%), 47 (22.17%), 14 (6.60%), 10 (4.72%), 2 (0.94%), 2 (0.94%), 2 (0.94%), 2(0.94%), and 2 (0.94%), respectively ([Figure 2]).
Out of 812 patients admitted in the surgical and medical ICU during the period of study, 131 (16.13%) patients developed AKI ([Table 6]).
|Table 6 Prevalence of acute kidney injury in intensive care unit patients during the study period|
Click here to view
There were significant associations between the length of hospital stay (LOS) and the AKIN staging. The mean±SD of LOS in stages I, II, and III was 10.47±5.71 11.08±5.44, and 12.54±54 days, respectively ([Table 7] and [Table 8]).
|Table 8 Mean±SD of length of hospital stay of the studied patients in acute kidney injury according to the Acute Kidney Injury Network staging|
Click here to view
As regards the complete blood count and coagulation profile results of all patients, the mean±SD of white blood cell, hemoglobin, hematocrit, platelet, prothrombin time, prothrombin concentration, and international normalized ratio was 15.64±7.22, 10.92±2.86, 36.16±35.53, 277.30±116.20, 16.22±7.47, 75.43±25.50, and 1.36±0.75, respectively ([Table 9]).
|Table 9 Mean±SD of complete blood count and coagulation profile of the studied patients|
Click here to view
As per the laboratory data results of all patients, the mean±SD of blood urea was 198.16±84.77 mg/dl (range: 45–407 mg/dl); the mean±SD of serum creatinine on admission was 5.55±4.41 mg/dl (range: 1.5–31 mg/dl); peak of serum creatinine was 6.31±4.28 mg/dl (range: 2.01–31 mg/dl); and serum creatinine on discharge was 2.95±2.36 mg/dl (range: 0.4–11.5 mg/dl). In addition, the mean±SD of serum calcium, phosphorus, uric acid, albumin, sodium, and potassium was 8.32±0.96, 5.19±1.62, 7.20±3.06, 3.13±0.66, 134.81±19.10, and 4.98±1.19, respectively ([Table 10]).
The number of patients with risk factors for developing AKI, including sepsis, chronic kidney disease (CKD) patients, diabetes and hypertension (HTN), age above 65 years, liver cirrhosis, HTN alone, diabetes alone, heart failure, and patients who developed intravenous contrast nephropathy was 71 (33.49%), 38 (17.92%), 35 (16.5%), 26 (12.26%), 11 (5.18%), 11 (5.18%), 10 (4.71%), 8 (3.77%), and 2 (0.94%), respectively ([Table 11]).
|Table 11 The risk factors for develop acute kidney injury in 212 studied patients|
Click here to view
The patients included in this study were divided into three groups according to the etiology of AKI (prerenal, renal, and postrenal causes). The number of patients in each group was as follows: 139 (65.6), 51 (24.1%), and 22 (10.4%) patients, respectively. There were significant associations with the severity of AKI in prerenal, renal, and postrenal causes (P>0.035) ([Table 12]).
The number of patients with prerenal, renal, and postrenal causes in stage III was 59 (42.45%), 28 (54.90%), and 14 (63.64%), respectively, which was significantly higher than the number of patients with prerenal, renal, and postrenal causes in stage I was 42 (30.21%), 15 (29.41%), 4 (18.18%), and in stage II was 38 (27.34%), 8 (15.69%), 4 (18.18%), respectively (P<0.05) ([Table 12]).
The prognosis of 212 studied patients with AKI was worse in patients with renal causes in whom complete recovery occurred in 10 (19.61%) patients and in patients with postrenal causes in whom complete recovery occurred in 18 (81.82%) patients, and it was better in patients with prerenal causes in whom complete recovery occurred in 67 (48.2%) patients ([Table 13]).
|Table 13 The relationship between the etiology of acute kidney injury and prognosis in 212 studied patients|
Click here to view
The causes of AKI of the studied patients, which included dehydration, sepsis, acute-on-CKD, hepatorenal syndrome, and multiorgan dysfunction syndrome were found in 82 (38.7%), 71 (33.5%), 38 (17.9%), 11 (5.2%), and 10 (4.7%) patients, respectively ([Table 14]).
Dehydration was diagnosed in 82 patients, of whom 21 died; sepsis was diagnosed in 71 patients, of whom 50 died; acute-on-CKD was diagnosed in 38 patients, of whom 11 died; hepatorenal syndrome was diagnosed in 11 patients, of whom eight died; and multiorgan dysfunction syndrome was diagnosed in 10 patients, of whom 10 died ([Table 14]).
Regarding the treatment of the studied patients, 150 (70.75%) patients were on conservative treatment, whereas 62 (29.25%) patients underwent hemodialysis (HD). As regards prognosis of the studied patients, complete recovery occurred in 95 (44.81%) patients, partial recovery occurred in 81 (38.21%) patients, and there was no recovery in 36 (16.98%) patients. As regards the outcome of the studied patients, 112 (52.8%) patients lived and 100 (47.2%) died ([Table 15]).
|Table 15 Treatment, prognosis, and outcome distribution of 212 studied patients with acute kidney injury|
Click here to view
In our study there was a highly significant association between modality of treatment and severity of AKI as all patients who underwent HD were in stage III.
| Discussion|| |
The mean±SD of age of 212 patients with AKI was 57.72±13.62 years, ranging between 22 and 85 years, of whom 137 (64.62%) were male patients and 75 (35.38%) were female patients. This increased incidence in male patients with AKI was also reported by Wijewickrama et al.  who found that 61.5% of AKI patients were male patient, with a mean age of 47.8 years; and also by Fan et al.  who found that 63.5% of AKI patients were male patients and 36.5% female patients, with their ages range from 39 to 68 years. However, other authors reported slightly increased female incidence up to 56.7% .
We did not find any association between patients’ age or sex and severity of AKI, which was noted previously by Fan et al.  and Wijewickrama et al. .
When the RIFLE criteria was applied to our patients, 25.9% were classified as risk, 29.24% were classified as injury, 15.56% were classified as failure, 17.92% were classified as loss, and 11.32% were classified as ESRD. Furthermore, in a study by Talaat et al. , 24% patients were classified as risk, 28.2% as injury, and 47.8% as failure under the RIFLE criteria.
When we categorized AKI patients according to the AKIN criteria, 61 (28.77%) patients were in stage I, 50 (23.58%) patients were in stage II, and 101 (47.64%) patients were in stage III. Similar results were previously reported by Fan et al. , Talaat et al. , and Mehta et al. .
The incidence of AKI was more common in ICU patients compared with patients in other hospital departments. The distribution of patients in surgical ICU was 73 (34.43%), in medical ICU it was 58 (27.36%), and in internal medicine department it was 47 (22.17%).
This was previously noted by Hoste and Schurgers  who reported AKI occurring in approximately 50% patients in ICU, and also by Wijewickrama et al.  who found that during ICU stay, 60.2% developed AKI.
Other authors reported that, the incidence of AKI was higher in the department of internal medicine (52.4%) then it was in the department of surgery (33.2%), ICU (14.4%), and the department of nephrology (14.8%) .
The incidence of ICU-acquired AKI reached 16.13% in our studied patients, which was almost similar to that reported previously by other authors, who found that the prevalence of AKI in ICU patients was 21.2 , 17 , 18 , and 22.6% .
The mean±SD of the LOS of the studied patients was 11.21±6.38 days . Using Kaplan–Meier curve it was revealed that the LOS was significantly associated with severity of AKI.
This was also reported before by Challiner et al.  who found that the severity of the injury correlates with the LOS, and by Xiaoxi et al.  who reported that LOS was significantly higher in patients with AKI, and increased with increasing severity of AKI. Moreover, Chijioke et al.  reported that a short duration of hospital stay is associated with better outcomes in patients with AKI, and Jinyoung et al.  reported that duration of AKI influenced mortality rates in hospitalized patients.
The incidence of AKI among the studied patients with sepsis, CKD, diabetes and HTN, elderly above 65 years, liver cirrhosis, HTN alone, diabetes alone, heart failure, and patients who developed intravenous contrast nephropathy was 71 (33.49%), 38 (17.92%), 35 (16.5%), 26 (12.26%), 11 (5.18%), 11 (5.18%), 10 (4.71%), eight (3.77%), and two (0.94%), respectively. Challiner et al.  reported that the presence of diabetes mellitus (DM), HTN, known CKD, sepsis, diuretics, and age above 65 years were all associated with an increased incidence of AKI.
Roberts et al.  reported that the most common AKI risk factors were HTN, patients treated with angiotensin-converting enzyme inhibitor and diuretics, and also patients with diabetes, CKD, and ischemic heart disease. Moreover, Rifkin et al.  found that the patients with AKI share several common risk factors including obesity, metabolic syndrome, diabetes, HTN, cardiovascular disease, and microalbuminuria.
The highest incidence of AKI in the presented patients occurred due to prerenal causes [139 (65.6%)] compared with renal [51 (24.1%)] and postrenal [22 (10.4%) causes]. This was in contrast to Fan et al.  who found that prerenal, renal, and postrenal AKI occurred in 36.5, 46.5, and 17.0% patients, respectively; the highest percent of AKI was due to renal causes.
The high incidence of AKI due to prerenal causes as dehydration and sepsis in our study was possibly due to the old age of the patients, which carries a higher incidence of sepsis-associated AKI, and also the presence of other comorbidities like DM, CKD, and liver disease. Similar results were previously reported by ,,.
In our study, 71 (33.5%) patients out of 212 presented with AKI occurring due to sepsis, which was in agreement with Lopes et al. , Cruz et al. , and Bagshaw et al. , who found that the incidence of sepsis-associated AKI was 31.4, 25.6, and 32.4%, respectively.
In our study 147 (69.34%) patients were oliguric and 65 (30.66%) were nonoliguric, and there was a significant correlation between UOP and severity of AKI. In addition, Bouchard et al.  and Hoste et al.  reported the incremental risk for oliguric AKI concurrent with other organ failures, sepsis, and need for dialysis as the major determinants of mortality associated with in-hospital AKI.
Measurement of UOP is advised for AKI patients. Several AKI guidelines have introduced it as a diagnostic criterion along with creatinine. Mehta et al.  and Jung et al.  reported that age and anuria duration were independent predictors of renal recovery.
The treatment schedule studied was as follows: 150 (70.75%) patients were on conservative treatment, whereas 62 (29.25%) patients underwent HD. AKI was due to prerenal causes in a large number of our patients; its treatment included correction of the primary cause of AKI, fluid replacement therapy, and nutritional support. Moreover, supportive therapies such as antibiotics and adequate nutrition were given according to the standard management practice. All medications that could potentially affect renal function were discontinued. This was in contrast to Mehta et al.  who reported that dialysis was more frequently used in low and lower middle-income countries.
In our study we found highly significant association between modality of treatment and severity of AKI as all patients who underwent HD were in stage III. This was also previously noted by other authors .
As regards prognosis in our study, complete recovery occurred in 95 (44.81%) patient, partial recovery occurred in 81 (38.21%) patients, and there was no recovery in 36 (16.98%) patients. Mehta et al.  reported that 28% of their patients had complete recovery and 36% had partial recovery.
In our study we found that there was a highly significant difference in the relationship between the etiology and prognosis of AKI. Prerenal and postrenal causes were associated with higher recovery rates than did renal causes.
In patients with postrenal causes (22 patients) complete recovery occurred in 18 patients, which was significantly higher than the number of partial and no recovery patients, three and one patients, respectively. Most likely, because kidney damage caused by obstruction is transient and mild and is reversible after removal of obstruction, similar results were reported by Fan et al. , who noticed that postrenal AKI was associated with a higher recovery rate.
In patients with prerenal causes (139 patients) complete recovery occurred in 67 patients, which was significantly higher than the number of partial and no recovery patients, 52 and 20 patients, respectively.
In our studied patients 112 (52.8%) patients lived and 100 (47.2%) died. This was in agreement with Talaat et al.  who reported an overall mortality rate of 51.7%.
| Conclusion|| |
The incidence of AKI was higher in ICU patients compared with the incidence in those in other hospital departments. The presence of risk factors like sepsis, CKD, heart failure, age more than 65 years, DM, HTN, and liver cirrhosis was associated with an increased development of AKI. Prerenal causes as dehydration and sepsis were the leading causes of AKI.
- Increasing the knowledge in primary care units about AKI and renal diseases regarding causes, symptoms, management, and when to refer for nephrologist or tertiary care hospital.
- Long-term follow-up of patients with AKI.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Parikh A, Shaw A. The economics of renal failure and kidney disease in critically ill patients. Crit Care Clin 2012; 28:99–111.
Wang HE, Muntner P, Chertow GM, Warnock DG. Acute kidney injury and mortality in hospitalized patients. Am J Nephrol 2012; 35:349–355.
Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet 2005; 365:417–430.
Andrew JP, Sayed A. Acute kidney injury: how do we define it? Ann Clin Biochem 2010; 47:4–7.
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute Dialysis Quality Initiative Workgroup: acute renal failure − definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8:R204–R212.
Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007 11:R31.
Wijewickrama ES, Ratnayake GM, Wikramaratne C, Sheriff R, Rajapakse S. Incidences and clinical outcomes of acute kidney injury in ICU: a prospective observational study in Sri Lanka. BMC Res Notes 2014; 7:305.
Fan H, Zhao Y, Zhu JH, Song FC. Urine neutrophil gelatinase-associated lipocalin in septic patients with and without acute kidney injury. Ren Fail 2014; 36:1399–1403.
Roberts G, Phillips D, McCarthy R, Bolusani H, Mizen P, Hassan M et al.
Acute kidney injury risk assessment at the hospital front door: what is the best measure of risk? Clin Kidney J 2015; 8:673–680
Talaat A, Elshahawy E, ElHammady AM, El-Assal M, Abdullah S. Epidemiology, clinical characteristics and outcome of acute kidney injury in intensive care units in Egyptian patients. Life Sci J 2014; 11:220–224.
Mehta RL, Burdmann EA, Cerdá J, Feehally J, Finkelstein F, García-García G et al.
Recognition and management of acute kidney injury in the International Society of Nephrology by25 Global Snapshot: a multinational cross-sectional study. Lancet 2016; 387:2017–2025.
Hoste EA, Schurgers M. Epidemiology of acute kidney injury: how big is the problem? Crit Care Med 2008 36:S146–S151.
Clermont G, Acker CG, Angus DC, Sirio CA, Pinsky MR, Johnson JP. Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int 2002; 62:986–996.
Chawla L, Abell L, Mazhari R, Egan M, Kadambi N, Burke HB et al.
Identifying critically ill patients at high risk for developing acute renal failure. Kid Int 2005; 68:2274–2280.
Santos WJ, Zanetta DM, Pires AC, Suzana MA, Emerson Q, Emmanuel A. Patients with ischemic, mixed and nephrotoxic acute tubular necrosis in intensive care unit. Crit Care 2006; 10:68–76.
Challiner R, James P, Paul L, Catherine F, Alastair J. Incidence and consequence of acute kidney injury in unselected emergency admissions to a large acute UK hospital trust. BMC Nephrol 2014; 15:84.
Xiaoxi Z, Gearoid MM, Steven MB, David WB, Sushrut SW. Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals. Clin J Am Soc Nephrol 2014; 9:12–20.
Chijioke A, Makusidi AM, Rafiu MO. Factors influencing hemodialysis and outcome in severe acute renal failure from Ilorin, Nigeria. Saudi J Kidney Dis Transpl. 2012; 23:391–396.
Jinyoung Y, Ji Sung L, Jiyeon L, Jin Seok J, Hyunjin N, Dong Cheol H, Soon H. Relationship between duration of hospital-acquired acute kidney injury and mortality: a prospective observational study. Korean J Intern Med 2015; 30:205–211.
Rifkin DE, Coca SG, Kalantar-Zadeh K. Does AKI truly lead to CKD? J Am Soc Nephrol 2012; 23:979–984.
Bello BT, Busari AA, Amira CO, Raji YR, Braimoh RW. Acute kidney injury in Lagos: pattern, outcomes, and predictors of in-hospital mortality. Niger J Clin Pract 2017; 20:194–199.
] [Full text]
Lopes JA, Jorge S, Resina C, Santos C, Pereira A, Neves J et al.
Acute kidney injury in patients with sepsis. Crit Care 2007; 11:411.
Cruz DN, Bolgan I, Perazella MA, Bonello M, de Cal M, Corradi V et al.
North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI): targeting the problem with RIFLE criteria. Clin J Am Soc Nephrol 2007; 2:418–425.
Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol 2007; 2:431–439.
Bouchard J, Acharya A, Cerda J. A prospective international multicenter study of AKI in the intensive care unit. Clin J Am Soc Nephrol 2015; 8:1324–1331.
Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN et al.
Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 2015; 41:1411–1423.
Jung H-Y, Lee J-H, Park Y-J, Kim S-U, Lee K-H, Choi J-Y et al.
Duration of anuria predicts recovery of renal function after acute kidney injury requiring continuous renal replacement therapy. Korean J Inter Med 2016; 31:930–937.
[Figure 1], [Figure 2]
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6], [Table 7], [Table 8], [Table 9], [Table 10], [Table 11], [Table 12], [Table 13], [Table 14], [Table 15]